Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Genmab puts down $54M for immunotherapy collaboration — ready to spend millions more
Endpoints
Thu, 07/12/18 - 06:27 pm
Tags:
Genmab, JNJ, Europe, cancer immunotherapy, Immatics
J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up?
Yahoo/Zacks.com
Thu, 07/12/18 - 11:52 am
Tags:
JNJ, earnings
Johnson & Johnson, looking for its Tremfya niche, starts up new trial program in Crohn's
Fierce Pharma
Wed, 07/11/18 - 11:35 am
Tags:
JNJ, Tremfya, MorphoSys, Janssen, Crohn's Disease, clinical trials
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
Tags:
M&A, biotech, Celgene, Sanofi, Impact Biomedicines, Bioverativ, GSK, Takeda, Shire, JNJ
Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest
Endpoints
Thu, 07/5/18 - 11:22 am
Tags:
Donald Trump, UK, Brexit, JNJ, GSK, Pharma CEOs, Alex Gorsky, Emma Walmsley
J&J scores third appeals win—this one for $55M—in talc powder litigation
Fierce Pharma
Tue, 07/3/18 - 10:13 am
Tags:
JNJ
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Thu, 06/28/18 - 09:34 am
Tags:
Amgen, ABP 710, JNJ, Merck, Remicade, biosimilars, rheumatoid arthritis
Dare to 'Dreem': J&J Invests in Sleep-Focused Medtech Startup
Medical Devices and Diagnostics Industry
Tue, 06/26/18 - 10:07 pm
Tags:
Dreem, JNJ, devices, neurotech
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
Fierce Pharma
Mon, 06/25/18 - 09:12 pm
Tags:
JNJ, Invokana, diabetes, heart failure
J&J's Drug Unit Chief Expands Portfolio in Executive Shakeup
Yahoo/Bloomberg
Sat, 06/23/18 - 12:58 pm
Tags:
JNJ, Joaquin Duato, reorganization
Johnson & Johnson hits the Big Apple with latest JLabs site
Mass Device
Thu, 06/21/18 - 11:09 pm
Tags:
JNJ, New York, NYC, incubators, innovation
New York Judge's Ruling Could Be Painful For Opioid-Makers Sued Over Addiction Crisis
Forbes
Tue, 06/19/18 - 09:53 am
Tags:
New York, opioids, opioid crisis, Purdue Pharma, JNJ
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Mon, 06/18/18 - 09:47 am
Tags:
Indorsia, Actelion, JNJ, insomnia
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Fri, 06/15/18 - 09:57 am
Tags:
Novartis, biosimilars, JNJ, Remicade, Amgen, Enbrel, autoimmune disease
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
CP Wire
Wed, 06/13/18 - 10:19 pm
Tags:
JNJ, NICE, Tremfya, psoriasis
Wed, 06/13/18 - 10:25 am
Tags:
JNJ, Tremfya, psoriasis
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Drug Delivery Business News
Tue, 06/12/18 - 11:28 pm
Tags:
JNJ, M&A, LifeScan, blood glucose monitoring, devices
Is There an End in Sight for J&J Divestitures?
Medical Devices and Diagnostics Industry
Sun, 06/10/18 - 07:00 pm
Tags:
JNJ, M&A, LifeScan, Fortive, devices
J&J gets $2.7 billion offer for sterilization unit from Fortive
Yahoo/Reuters
Wed, 06/6/18 - 09:59 pm
Tags:
JNJ, Fortive, M&A, sterilzation, Ethicon
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
Endpoints
Thu, 05/31/18 - 08:11 pm
Tags:
JNJ, esketamine, major depression

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.